Weight Loss
Retatrutide
The Triple Agonist
Complete guide to the GLP-1 / GIP / Glucagon triple receptor agonist. Reconstitution, weekly dosing protocols, titration schedules, stacking strategies, and safety.
Class
Triple Agonist — GLP-1 + GIP + Glucagon
Administration
Once weekly subcutaneous injection
Key Results
24–26% body weight loss in Phase 2 trials
Status
Phase 3 trials · FDA approval projected 2026–2027
Who this guide is for.
Those seeking significant weight loss with the most advanced peptide available. Targets three pathways simultaneously for superior results.
What's Inside
30 pages. 10 chapters.
Not a blog post. A protocol.
Evidence-Based
Every dosing recommendation is grounded in clinical research and practitioner protocols — not forum anecdotes.
Action-Ready
Not theory — a step-by-step operating manual from first reconstitution to cycle end.
Safety-First
Full side effect profiles, contraindications, and monitoring requirements. No information withheld.
Get the Retatrutide guide.
30 pages. 10 chapters. Everything from reconstitution to cycle end — in one PDF.